World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
31835
World Ranking
10501
National Ranking
5405

Overview

Lee M. Jampol is affiliated with Northwestern University in the United States. Their research primarily focuses on medicine, with a specialized emphasis in ophthalmology. The scientific contributions cover various subfields including radiology, nuclear medicine and imaging, molecular biology, neurology, and physiology.

The main topics addressed in their work involve retinal diseases and treatments, retinal imaging and analysis, retinal and optic conditions, ocular diseases including Behçet's syndrome, glaucoma and retinal disorders, retinal and macular surgery, as well as ocular oncology and treatments.

Frequent coauthors collaborating with Lee M. Jampol include Jennifer K. Sun, Adam R. Glassman, Daniel Martín, Maureen G. Maguire, and Cynthia R. Stockdale.

The scientist's publications often appear in various specialized journals, with frequent publication venues comprising:

  • JAMA Ophthalmology
  • Retina
  • Ophthalmology
  • Retinal Cases & Brief Reports
  • Ophthalmology Retina

Selected recent papers by Lee M. Jampol include:

  • Evaluation and Care of Patients with Diabetic Retinopathy, 2020, New England Journal of Medicine
  • Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study), 2020, Ophthalmology
  • Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration, 2020, Ophthalmology
  • Effect of Intravitreous Anti-Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy, 2021, JAMA Ophthalmology
  • Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy, 2020, JAMA

Best Publications

  • Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

    John A Wells;Adam R Glassman;Allison R Ayala

  • Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

    John A. Wells;Adam R. Glassman;Allison R. Ayala;Lee M. Jampol

  • Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.

    Marie Diener-West;Sandra M Reynolds;Donna J Agugliaro;Robert Caldwell

  • Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

    Jeffrey G. Gross;Adam R. Glassman;Lee M. Jampol;Seidu Inusah

  • Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

    Michael J. Elman;Allison Ayala;Neil M. Bressler;David Browning

  • Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1

    J. Arnold;D. Kilmartin;J. Olson;S. Neville

  • Pathophysiology of hypertensive retinopathy.

    Mark O.M. Tso;Lee M. Jampol

  • Multiple Evanescent White Dot Syndrome: I. Clinical Findings

    Lee Merrill Jampol;Paul A. Sieving;David Pugh;Gerald A. Fishman

  • The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19

    Lee M. Jampol;Claudia S. Moy;Claudia S. Moy;Timothy G. Murray;Sandra M. Reynolds

  • Nonsteroidal Anti-inflammatory Drugs in Ophthalmology

    Stephen J. Kim;Allan J. Flach;Lee M. Jampol

  • Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial

    Neil H. White;Wanjie Sun;Patricia A. Cleary;Ronald P. Danis

  • Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial

    Jeffrey G. Gross;Adam R. Glassman;Danni Liu;Jennifer K. Sun;Jennifer K. Sun

  • Quantifying Microvascular Abnormalities With Increasing Severity of Diabetic Retinopathy Using Optical Coherence Tomography Angiography.

    Peter L. Nesper;Philipp K. Roberts;Philipp K. Roberts;Alex C. Onishi;Haitao Chai;Haitao Chai

  • Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.

    Neil M. Bressler;Wesley T. Beaulieu;Adam R. Glassman;Kevin J. Blinder

  • Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa.

    Gerald A. Fishman;Leonardo D. Gilbert;Richard G. Fiscella;Alan E. Kimura

  • Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.

    Carl W. Baker;Adam R. Glassman;Wesley T. Beaulieu;Andrew N. Antoszyk

  • Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.

    Raj K Maturi;Adam R Glassman;Danni Liu;Roy W Beck

  • White spot syndromes of the retina: a hypothesis based on the common genetic hypothesis of autoimmune/inflammatory disease

    Lee Merrill Jampol;Kevin G. Becker

  • The Expanded Spectrum of Focal Choroidal Excavation

    Ron Margolis;Sri Krishna Mukkamala;Lee M. Jampol;Richard F. Spaide

  • Treatment of polypoidal choroidal vasculopathy with photodynamic therapy.

    Richard F. Spaide;Irene Donsoff;Deborah L. Lam;Lawrence A. Yannuzzi

Frequent Co-Authors

Neil M. Bressler
Neil M. Bressler Johns Hopkins University School of Medicine
Lawrence A. Yannuzzi
Lawrence A. Yannuzzi Manhattan Eye, Ear and Throat Hospital
Susan B. Bressler
Susan B. Bressler Johns Hopkins University School of Medicine
Frederick L. Ferris
Frederick L. Ferris National Institutes of Health
Edwin M. Stone
Edwin M. Stone University of Iowa
K. Bailey Freund
K. Bailey Freund New York University
Lloyd Paul Aiello
Lloyd Paul Aiello Harvard University
Maureen G. Maguire
Maureen G. Maguire University of Pennsylvania
Ursula Schmidt-Erfurth
Ursula Schmidt-Erfurth Medical University of Vienna
Richard F. Spaide
Richard F. Spaide Manhattan Eye, Ear and Throat Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career alternatives in healthcare? Online study options offer adaptable pathways, whether you're just starting out or seeking career advancement. Nurses, for example, can fast-track their qualifications through programs like the cheapest rn to bsn program online, designed for working RNs to earn a bachelor’s degree efficiently and affordably.

If you hold a bachelor’s in another field, direct entry online msn programs make it possible to pursue a master’s in nursing even without prior nursing experience. These flexible options help address industry demand for highly skilled professionals.

To minimize costs while reaching the highest academic level in nursing, many seek the online phd in nursing. This can prepare you for leadership, research, and faculty positions from anywhere.

For those looking for accessible entry points, learn more about whats the easiest nursing program to get into? to help you gain admission and get started on a rewarding career in healthcare.

Best Scientists Citing Lee M. Jampol

Trending Scientists